Lessee, Operating Lease, Liability, to be Paid of Edesa Biotech, Inc. from 31 Mar 2023 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Edesa Biotech, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2023 to 30 Sep 2024.
  • Edesa Biotech, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2024 was $20,019, a 80% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Edesa Biotech, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $20,019 -$79,602 -80% 30 Sep 2024 10-K 13 Dec 2024 2024 FY
Q2 2024 $39,562 -$82,971 -68% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q3
Q1 2024 $59,935 -$80,046 -57% 31 Mar 2024 10-Q 10 May 2024 2024 Q2
Q4 2023 $81,645 31 Dec 2023 10-Q 09 Feb 2024 2024 Q1
Q3 2023 $99,621 30 Sep 2023 10-K 15 Dec 2023 2023 FY
Q2 2023 $122,533 30 Jun 2023 10-Q 09 Aug 2023 2023 Q3
Q1 2023 $139,981 31 Mar 2023 10-Q 11 May 2023 2023 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.